
NeuroFieldz makes NeuroVEP, a portable diagnostic device that provides objective, response-free testing of neuro-visual disorders. The device measures Visual Evoked Potentials (VEP) using a NeuroDot sensor and patented Electric Field Encephalography (EFEG) hardware, and analyzes signals with AI and machine learning to deliver rapid neuro-optical assessments. NeuroVEP combines a lightweight headset and wireless sensor system with smartphone integration to enable point-of-care testing without specialized lab equipment. The company operates as a medical device and SaaS/Licensing provider targeting ophthalmology and neurology clinics and leverages its patents to expand diagnostic testing options in clinical practice.

NeuroFieldz makes NeuroVEP, a portable diagnostic device that provides objective, response-free testing of neuro-visual disorders. The device measures Visual Evoked Potentials (VEP) using a NeuroDot sensor and patented Electric Field Encephalography (EFEG) hardware, and analyzes signals with AI and machine learning to deliver rapid neuro-optical assessments. NeuroVEP combines a lightweight headset and wireless sensor system with smartphone integration to enable point-of-care testing without specialized lab equipment. The company operates as a medical device and SaaS/Licensing provider targeting ophthalmology and neurology clinics and leverages its patents to expand diagnostic testing options in clinical practice.
Product: NeuroVEP — portable AI-powered system that measures Visual Evoked Potentials (VEP) for neuro-visual/ophthalmic testing
Technology: NeuroDot sensor / Electric Field Encephalography (EFEG), dry nanostructured bioelectrodes, smartphone-driven stimulus, AI signal analysis
Regulatory status: Prototype/under development — not approved for marketing or commercial use
Founder: Srinivas Sridhar, PhD (founder; academic lead)
Funding signal: $2,000,000 NIH STTR Phase II grant (announced Sep 4, 2019); multiple other NIH/NSF and university grants reported
IP: U.S. patent No. 11,701,046 B2 (patent date Jul 18, 2023) related to a portable brain-and-vision diagnostic/therapeutic system
Neuro-visual diagnostics for ophthalmology and neurology (objective VEP-based testing)
2013
Biotechnology
$2,000,000
Award to develop a Neuro-Optical Diagnostic System for Macular Degeneration
Phase I STTR award related to macular degeneration
Phase I SBIR award related to an amblyopia theranostic virtual reality headset
NSF Phase I SBIR / I-Corps-related awards referenced in company materials
Grant to commercialize the NeuroDot sensor using EFEG technology